Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation

Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Michael F Murphy; Alan Tinmouth

doi:10.1002/14651858.CD010984

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation

Cochrane Database Syst Rev. 2014:(3):CD010984. doi: 10.1002/14651858.CD010984.

Authors

Lise J Estcourt¹, Simon Stanworth¹, Carolyn Doree², Marialena Trivella³, Sally Hopewell⁴, Michael F Murphy⁵, Alan Tinmouth⁶

Affiliations

¹ Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.
² Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.
³ Cochrane Editorial Unit, The Cochrane Collaboration, Oxford, UK.
⁴ Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
⁵ NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.
⁶ Medicine (hematology) and Pathology Centre for Transfusion Research, The Ottawa Health Research Institute and the University of Ottawa, Ottawa, Canada.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine whether different doses of prophylactic platelet transfusions (platelet transfusions given to prevent bleeding) affect their efficacy and safety in preventing bleeding in patients with haematological disorders after chemotherapy with or without stem cell transplantation.

Publication types

Research Support, Non-U.S. Gov't

Abstract

Publication types

Grants and funding